NLRP1 and malignant colon neoplasm: To our knowledge, this is the first report suggesting that the expression of NALP1 is reduced in colon cancer tissue relative to normal tissue and that DAC can restore the expression of NALP1 in colon cancer both in vivo and in vitro to suppress colon cancer.